Find a Top Oncologist Near Me – Book an Appointment Instantly

Chirag Shah, MD, is a medical oncology and hematology specialist at Advanced Cancer Care of New Jersey, PC. Dr. Shah provides personalized, state-of-the-art cancer care to residents in Toms River, New Jersey. 

Dr. Shah attended M. P. Shah Medical College in Gujarat, India, completing his medical degree in 1992. He then pursued post-graduate training in internal medicine at Edgewater Medical Center in Chicago, Illinois, where he served as chief resident. 

After completing his residency, he joined an oncology and hematology fellowship program at the State University of New York (SUNY)’s Upstate Medical University and later joined the faculty as an assistant professor. 

Dr. Shah has published in numerous peer-review journals and was the recipient of a lung cancer research grant. In addition, he was a principal investigator for many clinical trials. 

In 2010, Dr. Shah decided to move to New Jersey to be closer to his loved ones. He joined the private practice of Anil R Ponnambalam MD, PC, and has worked with him since 2010. 

While Dr. Shah has since taken over the practice and changed the name to Advanced Cancer Care of New Jersey, PC, in 2017, his steps to ensure proper care never change. Each cancer patient’s story is unique, but he always approaches each treatment with the same empathy and compassion.

Patient Reviews:

"Dr Modasi is very thorough in diagnosing & then explaining his care plan in “layperson” terms. He takes the time to answer questions on the procedure. Dr Modasi will do whatever he can to assure a successful procedure & recovery. I’m thankful for his help with my health issues." -Jeff

Dr. Cory Heal is a radiation oncologist who has expertise in a full breadth of radiation oncology treatments for both malignant and benign diseases in children and adults.

Before joining Arizona Center for Cancer Care, Dr. Heal received a Bachelor of Science from Brigham Young University and his Medical Doctorate from Drexel University. He then completed an internship in Internal Medicine at Abington Memorial Hospital and a residency in radiation oncology at the University of Arizona, where he served as Chief Resident. 

Dr. Heal specializes in the treatment of malignancies of the breast, prostate, lung, skin, head and neck, gynecological tract, gastrointestinal tract, central nervous system, hematologic/lymphatic systems, and musculoskeletal systems. He also treats a wide array of benign diseases that benefit from radiation. Dr. Heal utilizes the latest treatment techniques in his practice, including Stereotactic Radiosurgery (SRS), Intensity Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), PLUVICTO, LUTATHERA, and Stereotactic Ablative Radiotherapy (SABR/SBRT). Dr. Heal has additional specialized training and research interests in the use of HDR brachytherapy for several anatomic sites. His other research interests include patient safety and quality improvement.

An Arizona native who grew up in the East Valley, Dr. Heal feels privileged to serve the community he loves. He always seeks to be an advocate for his patients as he guides them through treatment. He enjoys the lasting relationships he develops with his patients and their families and feels honored to take part in their care.

Dr. Heal and his wife, Emily,  have four children. Outside of medicine, Dr. Heal loves spending his free time being a dad, cooking new foods in the kitchen, and making memories with his family outdoors.

Patient Reviews:

"Dr. Heal and his team were so thorough and thoughtful with explanations which reduced my anxiety and made daily radiation appointments very easy to manage!" -Wendy

"Couldn't be more satisfied with Dr. Heal. He's a wonderful person both personally and professionally, making sure to explain every aspect of the treatment for my brain cancer, as well as being an all-around good guy! I'm a lucky man." - Daniel

Dr. Justin Goldfarb specializes in medical oncology, internal medicine, and hematology. 

Growing up in suburban Detroit, Dr. Goldfarb followed his true passion to become a hematologist and medical oncologist. A published author on topics including lymphoma and breast cancer, he is double board-certified in medical oncology and internal medicine, and fellowship-trained in hematologic disorders and solid tumors.

Dr. Goldfarb earned a bachelor’s degree from the University of Colorado at Boulder and holds a medical degree from Midwestern University in Chicago. He completed an internal medicine residency at Rush University Medical Center in Chicago, followed by a medical oncology fellowship at Baylor University Medical Center in Dallas. With academic appointments at Pritzker School of Medicine at the University of Chicago and Midwestern University, Dr. Goldfarb thoroughly enjoys teaching and mentoring medical students.

Patient Reviews:

"The care I receive from Dr. Goldfarb is exceptional. He listens attentively to my concerns and he provided me with a treatment plan that yields positive results. The entire team at the clinic display a high level of professionalism and make me feel comfortable while I'm there . Nicole Lee is exceptional as well." -Christian

"Dr Goldfarb has been helping me fight lung cancer for two years and is a very caring person." -JC

Dr. Abhimanyu Ghose clinical interests include treating patients with all types of cancer, including lung, gastrointestinal, breast, genitourinary (bladder, prostate, renal), skin, myeloma, lymphomas, and other blood disorders. Dr. Ghose has more than 25 published peer reviewed articles in field of oncology and has presented at national and international conferences.

Dr. Ghose believes in treating his patients with the same level of respect and compassion he would offer to his family members. He is a strong advocate for his patients. His approach is individualized to each patient because each patient’s condition and situation in life is unique.

In his free time, Dr. Ghose enjoys spending time with his family, dining out, hiking, and traveling. He is also an avid tennis player.

Patient Reviews:

"I have been treating with Dr. Abhimanyu Ghose since my diagnosis in December of 2018. I was diagnosed with Stage IV, Non Small Cell Lung cancer. I began treatment March of 2019 with chemotherapy and Keytruda. After completing chemotherapy I have remained on Keytruda since the beginning. I have been in remission for over a year and my CT scans continue to confirm no evidence of disease. I trust Dr. Ghose and his team to continue to make the best treatment plans possible for me. I also believe Keytruda has been a life saver for me! I continue to have infusions every 3 weeks with little to no adverse reactions. I am grateful to have Dr. Ghose and the infusion nurses taking care of me." -Nancy

"Have had wonderful care by Dr. Ghose thru my cancer treatment and follow ups for last 4 years. He is attentive and caring and positive. Easy to understand his explanations and thorough. Office experiences always efficient." -Jeff

Dr. Parmjeet Kumar Banghar specializes in hematology, medical oncology, and internal medicine. He joined Arizona Center for Cancer Care in 2008 when his team at Arizona Center for Hematology and Oncology partnered with the practice.

Currently, Dr. Banghar is a member of the American Society of Clinical Oncology and American Society of Hematology. He has participated in a research study involving cerebrovascular diseases and been published in several journals, including Leukemia Research and the Indian Journal of Medical Sciences. He has also presented on a number of topics, including sonographic evaluation of the spleen in sickle cell syndromes, lennox gastaut syndrome and sweet syndrome in a patient with acute myeloid leukemia.

Patient Reviews:

"This doctor is smart and knows cancer. The staff is the best. My nurses who give me shots are the best! Highly reccomend this office." -Lina

"I have been Dr. Banghar's patient since 2019 and just found out I could give him a review. Wish I had been told this before. He is an excellent provider. He has made me feel confident about my treatment which I think has/had a tremendous amount of impact on my care and the outcome. I would recommend him and the facility in a heart beat." -Felicia

Getting diagnosed with cancer is very difficult for patients and their families but getting treatment for cancer should not be. Dr. Agarwal approaches all cancer patients with the goal of giving them the most up-to-date and individualized cancer treatment in an efficient way so they can continue to live their lives as close to normal as possible

Dr. Agarwal specializes in all different types of cancer and blood related problems such as lung, gastrointestinal, prostate, genitourinary, gynecologic, neurologic, lymphomas, leukemia, anemia, platelets clotting disorders, etc.  He is also interested in clinical trials and has completed advanced training in clinical trials and research. In addition, he has published several papers and has presented at national and international cancer meetings.

In his free time, Dr. Agarwal enjoys traveling, watching movies, playing tennis and golf.

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Dr. Christopher Biggs specializes in radiation oncology and is an expert in radiosurgery and gynecological oncology.

Dr. Biggs co-founded Arizona Center for Cancer Care in 2008 with Drs. Devinder Singh, Daniel Reed and Terry Lee. He attended the University of Arizona, where he received his Bachelor of Science degree in Molecular and Cellular biology. His interest in cancer research took him to the University of Southern California, under the Borchard Cancer Research Fellowship. There, he performed research on the molecular genetics of cancer at the Norris Cancer Center and at LA Children’s Hospital. After completing his Doctor of Philosophy degree, he moved to Stanford University, where he earned his medical degree, and developed an interest in radiation oncology. Dr. Biggs completed his residency in radiation oncology at the University of California, San Francisco, where he eventually served as chief resident.

For five years, Dr. Biggs performed radiosurgery at Barrow Neurological Institute and also served as director of the Baptist Oncology Center.

Dr. Biggs is certified by the American Board of Radiology and is a Diplomat of the American Society of Therapeutic Radiation Oncology. He is a member of the American Association for Cancer Research, Radiology Society of North America, American Society of Therapeutic Radiation Oncology and the American Association of Advancement of Science.

Dr. Biggs is a multi-year “Top Doc” honoree by Phoenix Magazine.

Patient Reviews:

"My experience was great I even had to travel from Yuma AZ for my treatments. DR Biggs made everything go as easy and painless for me. his staff were extremely kind and professional just like him! I appreciate so much for their empathy they had for me and my battle with cancer. Thank you from the bottom of my heart. I highly recommend this office." -Jen

"The office visit was for my husband Jessie Wilson. Dr. Biggs is excellent at relieving any anxiety we had going in. He took the time to explain everything as well as talking about personal info to get to know us better. We left feeling very relaxed and confident in his care moving forward. We highly recommend Dr. Biggs and his entire staff to anyone who needs treatment!" -Linda

. 

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Dr. Pepple joined Arizona Premier Surgery in 2017. He is Board Certified in general surgery by the American Board of Surgery. Transitioning from a large academic center, he brings with him years of experience in the management of some of the most complex surgical patients. 

Patient care is deeply personal to him, and as such, he possesses an unyielding dedication to those who entrust him with their care. He will work with each patient to provide a wide range of surgical treatment options, and when appropriate, non-surgical options. He firmly believes that a multi-disciplinary approach to patient care provides optimal results. His clinical interests include benign and malignant hepatobiliary surgery, minimally invasive/robotic surgery, and skin malignancies (melanoma). In addition, he performs a broad range of general surgery, including excising/resecting skin lesions (cysts, squamous cell, melanoma), and dialysis surgery.

Patient Reviews:

"Dr. Pepple is held in really high regard in the medical community and I can see why. As a nurse practitioner, I asked a bunch of people who they recommend for general surgery and Dr pepple was always the top pick within the Honor Health network. A friend even spoke to an oncologist at the Mayo Clinic who said my husband was in Great hands with Dr. Pepple. He removed cancer from my husband and although he deals with much more devastating cancers than what my husband had, he was genuine, kind and patient. He spent time explaining everything to us. I would go to him if I ever needed a general surgeon. Thank you for everything you have done for us. You do great work and it was easy to trust you. There is always hope and people are good, especially you. Thank you, Thank you, Thank you." -Jamie

"Dr Pepples operated on my husband in march 2023 for a huge groin hernia and he had some other serious complications. Another surgeon wouldn’t even operate because of the complications & his age. Dr Peeples agreed to do and he did an excellent job. He & the staff are super professional and caring. He’s an excellent surgeon." -Linda

Arizona Center for Cancer Care is a cancer center without walls, offering the best doctors, best treatments, best technologies, and best research to give patients the best care possible. With offices in Avondale, Chandler, Gilbert, Glendale, Mesa, Phoenix, Scottsdale, Surprise, Anthem, Peoria, Fountain Hills, Wickenburg, Apache Junction, Sun City, Sun City West, Goodyear, Prescott Valley, and Tempe, Arizona, the multi-specialty practice cares for more than 30,000 patients across the Valley.

Arizona Center for Cancer Care specializes in treating many types of cancer, including multiple myeloma, colon, head and neck, breast, skin, and pancreatic, as well as brain cancer, lung cancer, and gastrointestinal cancer. 

The practice uses the most current treatment options available, including various forms of radiation oncology and medical oncology, and hematology. The center also includes experts in gynecologic oncology and breast surgery and has a newly diagnosed breast cancer clinic.

The board-certified radiation oncologists at Arizona Center for Cancer Care use positron emission tomography/computed tomography (PET/CT) imaging to reveal the presence and severity of cancer and create an effective treatment plan.

Dedicated to providing its patients with the most current drugs and therapies available, Arizona Center for Cancer Care participates in multiple clinical trials. 

Cancer is a disease of survivors, and Arizona Center for Cancer Care is keeping it that way.  

For comprehensive, high-quality cancer care, call Arizona Center for Cancer Care or schedule an appointment online today. Telemedicine appointments are available.

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/